|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001779,
umls-concept:C0009647,
umls-concept:C0026565,
umls-concept:C0030705,
umls-concept:C0038952,
umls-concept:C0040736,
umls-concept:C0205156,
umls-concept:C0205179,
umls-concept:C0332293,
umls-concept:C0376545,
umls-concept:C0522536,
umls-concept:C1280500
|
|
pubmed:issue |
27
|
|
pubmed:dateCreated |
2005-9-19
|
|
pubmed:abstractText |
Older age and a previously failed autologous stem-cell transplantation (SCT) are poor prognostic factors for patients receiving myeloablative conditioning and allogeneic SCT. Reduced-intensity conditioning (RIC) regimens achieved a significant reduction of treatment-related mortality, but the influence of previously described risk factors on the outcome of this novel transplantation strategy have not been fully analyzed yet.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BacigalupoAA,
pubmed-author:BandiniGG,
pubmed-author:BregniMM,
pubmed-author:CiceriFF,
pubmed-author:CorradiniPP,
pubmed-author:DoderoAA,
pubmed-author:FarinaLL,
pubmed-author:GianniA MAM,
pubmed-author:LocasciulliAA,
pubmed-author:LucesoleMM,
pubmed-author:MariotteNN,
pubmed-author:OlivieriAA,
pubmed-author:PatriarcaFF,
pubmed-author:RambaldiAA,
pubmed-author:ScimèRR,
pubmed-author:TarellaCC,
pubmed-author:ValagussaPP,
pubmed-author:ZallioFF
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
20
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6690-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16170177-Adult,
pubmed-meshheading:16170177-Age Factors,
pubmed-meshheading:16170177-Aged,
pubmed-meshheading:16170177-Analysis of Variance,
pubmed-meshheading:16170177-Female,
pubmed-meshheading:16170177-Graft Rejection,
pubmed-meshheading:16170177-Graft Survival,
pubmed-meshheading:16170177-Graft vs Host Disease,
pubmed-meshheading:16170177-Hematologic Neoplasms,
pubmed-meshheading:16170177-Humans,
pubmed-meshheading:16170177-Italy,
pubmed-meshheading:16170177-Male,
pubmed-meshheading:16170177-Middle Aged,
pubmed-meshheading:16170177-Neoplasm Staging,
pubmed-meshheading:16170177-Probability,
pubmed-meshheading:16170177-Prognosis,
pubmed-meshheading:16170177-Prospective Studies,
pubmed-meshheading:16170177-Remission Induction,
pubmed-meshheading:16170177-Risk Assessment,
pubmed-meshheading:16170177-Stem Cell Transplantation,
pubmed-meshheading:16170177-Survival Analysis,
pubmed-meshheading:16170177-Transplantation, Autologous,
pubmed-meshheading:16170177-Transplantation, Homologous,
pubmed-meshheading:16170177-Transplantation Conditioning,
pubmed-meshheading:16170177-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies.
|
|
pubmed:affiliation |
Divisione of Ematologia and Ufficio Operativo, Istituto Nazionale Tumori, Universitá di Milano, Milano, Italy. paolo.corradini@istitutotumori.mi.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
